{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-dominant-pseudohypoaldosteronism-type-1","columns":[{"gene":"","key":"population-e7a6b39042f19d03d874","label":"Pseudohypoaldosteronism, type I, autosomal dominant","mondoId":"MONDO:0008329","onsetQualifier":null,"originColumnKey":"MONDO:0008329/OMIM:177735","originalViews":[{"key":"MONDO:0008329/OMIM:177735","label":"Pseudohypoaldosteronism, type I, autosomal dominant","scopeLabel":"OMIM:177735","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["02f489c2acebf0107b86849e167370ad54aecbf596d51aa93d5a744446d5dda0","1f0193fbd44a656a14a65844ede731460933c04c7ac3494f676f7d2789454fed","306a7355fdc809128abe56f855412b35c1f3658d3a033a1809e9a0ddc41b3622","40dc631d799097bdb601e0f69c9651ca077d8d4ec085740f72a2b9daa59b63f4","476ddca1ac7272515175513f1decf09c12f9522c55e6c7d5e40cb1ecbc1a5085","52467468312508efc3f7caa1d82541d8708006b6ad3c4bcd557d7026ff0773e9","616da5a38b58d7bb798a51839d9a3ea4441e169b50e59e2f01936db2799e6cce","743c0f7afaddc389aa0df90baf2177ee0f23747b2289f6842cd77ec9a3b10870","9c812a63e149d1d320ba60cebd74480c21dc1af5d284286cbd9fd4021c91dd5d","a4128012eabe1f7df9cd8e147854f8732b843cc09758ffd38c84561ab9262053","c92c460fe4f735596e028fdefc71c0ba33ced64180c9a31b8c25bc36cfb4204c","e7e2b6ab88dea5a95d757e7556df7782ba80b9e838db51e05f931894148e2d2b","f37f90ab1f247e34acc21833df4815113b66ef84288262ae926b65f153e36b73"],"recordQualifiers":{},"scopeLabel":"OMIM:177735","sourceIds":["OMIM:177735"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e7a6b39042f19d03d874"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001944","HP:0002014","HP:0001508","HP:0011968","HP:0000841","HP:0002153","HP:0002902"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":13,"sourceGroups":{"omim":9,"published":4}},"features":[{"hpoId":"HP:0001944","label":"Dehydration","primary":true},{"hpoId":"HP:0002014","label":"Diarrhea","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":true},{"hpoId":"HP:0000841","label":"Hyperactive renin-angiotensin system","primary":true},{"hpoId":"HP:0002153","label":"Hyperkalemia","primary":true},{"hpoId":"HP:0002902","label":"Hyponatremia","primary":true},{"hpoId":"HP:0002615","label":"Hypotension","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0000848","label":"Increased circulating renin concentration","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0008242","label":"Pseudohypoaldosteronism","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"Renal pseudohypoaldosteronism type 1 is a disorder of electrolyte metabolism characterized by excess loss of salt in the urine, failure to thrive and dehydration. Symptoms usually begin in the newborn period. Some adults who have renal pseudohypoaldosteronism type 1 may have elevated aldosterone levels, but no history of clinical disease. Renal pseudohypoaldosteronism type 1 exhibits autosomal dominant inheritance with variable expression. It is caused by by genetic changes in the mineralocorticoid receptor gene (NR3C2).","mondoId":"MONDO:0008329","node":{"canonicalSlug":"autosomal-dominant-pseudohypoaldosteronism-type-1","comparisons":[{"documentSha256":"b7ea6149f020315501618ec6ea647841ca75511c7d601aa67842f4de782a9070","key":"legacy-pseudohypoaldosteronism-type-1","kind":"legacy","label":"pseudohypoaldosteronism type 1","memberIds":["MONDO:0008329","MONDO:0009917","MONDO:0019161","MONDO:0859317","MONDO:0859318"],"mondoId":"MONDO:0019161","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pseudohypoaldosteronism-type-1.b7ea6149f020315501618ec6ea647841ca75511c7d601aa67842f4de782a9070.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant pseudohypoaldosteronism type 1","originalSourceId":"ORPHA:171871","paragraphs":["Renal pseudohypoaldosteronism type 1 is a disorder of electrolyte metabolism characterized by excess loss of salt in the urine, failure to thrive and dehydration. Symptoms usually begin in the newborn period. Some adults who have renal pseudohypoaldosteronism type 1 may have elevated aldosterone levels, but no history of clinical disease. Renal pseudohypoaldosteronism type 1 exhibits autosomal dominant inheritance with variable expression. It is caused by by genetic changes in the mineralocorticoid receptor gene (NR3C2)."],"rawAttribution":"MONDO:0008329","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:23Z","upstream":"GARD:0009145","url":"https://rarediseases.info.nih.gov/diseases/9145"},"ownColumnKeys":["population-e7a6b39042f19d03d874"],"publication":"published","relationships":[{"kind":"parent","label":"pseudohypoaldosteronism type 1","mondoId":"MONDO:0019161","slug":"pseudohypoaldosteronism-type-1"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"reported","key":"02f489c2acebf0107b86849e167370ad54aecbf596d51aa93d5a744446d5dda0","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1f0193fbd44a656a14a65844ede731460933c04c7ac3494f676f7d2789454fed","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"306a7355fdc809128abe56f855412b35c1f3658d3a033a1809e9a0ddc41b3622","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"40dc631d799097bdb601e0f69c9651ca077d8d4ec085740f72a2b9daa59b63f4","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000841","is_excluded":false,"label":"Hyperactive renin-angiotensin system","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"476ddca1ac7272515175513f1decf09c12f9522c55e6c7d5e40cb1ecbc1a5085","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"52467468312508efc3f7caa1d82541d8708006b6ad3c4bcd557d7026ff0773e9","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"616da5a38b58d7bb798a51839d9a3ea4441e169b50e59e2f01936db2799e6cce","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001944","is_excluded":false,"label":"Dehydration","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"743c0f7afaddc389aa0df90baf2177ee0f23747b2289f6842cd77ec9a3b10870","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"PMID:9662404","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"9c812a63e149d1d320ba60cebd74480c21dc1af5d284286cbd9fd4021c91dd5d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002615","is_excluded":false,"label":"Hypotension","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a4128012eabe1f7df9cd8e147854f8732b843cc09758ffd38c84561ab9262053","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0008242","is_excluded":false,"label":"Pseudohypoaldosteronism","onset_id":null,"reference":"PMID:9662404","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c92c460fe4f735596e028fdefc71c0ba33ced64180c9a31b8c25bc36cfb4204c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000848","is_excluded":false,"label":"Increased circulating renin concentration","onset_id":null,"reference":"OMIM:177735","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e7e2b6ab88dea5a95d757e7556df7782ba80b9e838db51e05f931894148e2d2b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"PCS","frequency_raw":"3/5","hpo_id":"HP:0002902","is_excluded":false,"label":"Hyponatremia","onset_id":null,"reference":"PMID:9662404","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f37f90ab1f247e34acc21833df4815113b66ef84288262ae926b65f153e36b73","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:177735","disease_name":"Pseudohypoaldosteronism, type I, autosomal dominant","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0002153","is_excluded":false,"label":"Hyperkalemia","onset_id":null,"reference":"PMID:9662404","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9145\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008329\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0009145</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Renal pseudohypoaldosteronism type 1 is a disorder of electrolyte metabolism characterized by excess loss of salt in the urine, failure to thrive and dehydration. Symptoms usually begin in the newborn period. Some adults who have renal pseudohypoaldosteronism type 1 may have elevated aldosterone levels, but no history of clinical disease. Renal pseudohypoaldosteronism type 1 exhibits autosomal dominant inheritance with variable expression. It is caused by by genetic changes in the mineralocorticoid receptor gene (NR3C2).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9145\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-dominant-pseudohypoaldosteronism-type-1","sourceDocuments":[{"name":"GARD: Autosomal dominant pseudohypoaldosteronism type 1","reviewed":null,"source_release":"2026-10-25T03:40:23Z","url":"https://rarediseases.info.nih.gov/diseases/9145"},{"name":"MONDO: autosomal dominant pseudohypoaldosteronism type 1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0008329"}],"sourceNote":"","synonyms":["autosomal dominant pseudohypoaldosteronism type 1","PHA1A","pseudohypoaldosteronism type 1 autosomal dominant","pseudohypoaldosteronism type 1, dominant","pseudohypoaldosteronism type i, autosomal dominant","pseudohypoaldosteronism, type I, autosomal dominant","renal PHA1","renal pseudohypoaldosteronism type 1"],"takeawayHtml":"","title":"autosomal dominant pseudohypoaldosteronism type 1"},"schemaVersion":1}
